Enveric Biosciences, Inc. (ENVB)
3.93
+0.17
(+4.52%)
USD |
NASDAQ |
Jan 14, 11:53
Enveric Biosciences EPS Diluted (Quarterly): -10.81 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 0.0993 |
| iBio, Inc. | -0.108 |
| Pasithea Therapeutics Corp. | -0.4081 |
| Atai Beckley, Inc. | -0.2807 |
| HeartBeam, Inc. | -0.1528 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.874M |
| Total Expenses (Quarterly) | 1.874M |
| Enterprise Value | -1.809M |
| Earnings Yield | -2.07K% |
| Normalized Earnings Yield | -2075.34 |